Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05091346 |
|---|---|
| Brief Title: | A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors |
| First Submitted : | October 14, 2021 |
| First Submitted that Met QC Criteria : | October 14, 2021 |
| First Posted : | October 25, 2021 |
| Last Update Submitted that Met QC Criteria : | December 1, 2023 |
| Last Update Posted : | December 4, 2023 |